| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Rinku General Medical Center, 2-23 Rinkuorai-kita, Izumisano City, Osaka 598-8577, Japan. Received July 12, 2001; revision requested August 5; final revision received March 18, 2002; accepted March 26. Address correspondence to K.A.
PURPOSE: To investigate the effect of different iodine concentrations of contrast material on aortic and hepatic enhancement and the detectability of hypervascular hepatocellular carcinoma (HCC) with multi–detector row computed tomography (CT) and a uniphasic contrast material injection technique.
MATERIALS AND METHODS: Two hundred one patients with known or who were suspected of having HCC underwent multi–detector row CT; 58 patients with hypervascular HCC were identified. First-, second-, and third-phase scanning was started with the aortic arrival times plus 15 seconds, plus 30 seconds, and plus 105 seconds, respectively. All patients were assigned randomly into two groups. Patients in groups A and B received iopamidol with an iodine concentration of 300 mg/mL and 370 mg/mL, respectively, with the same total iodine load per patient per body weight. The liver and aorta enhancement and tumor-to-liver contrast (TLC) were measured. Depiction of hepatic arteries was evaluated visually by two radiologists.
RESULTS: During the first phase, aortic enhancement was significantly (P < .01) higher in group B, with no significant difference in hepatic enhancement between the two groups. During the second phase, aortic enhancement was significantly (P < .01) higher in group A, with no significant difference in hepatic enhancement. The TLC was significantly (P < .01) higher in group B during the first phase, but there was no significant difference between the two groups during the second phase. There was no significant difference in any parameters between the two groups during the third phase. Depiction of the hepatic arteries in group B was significantly (P < .05) superior to that in group A.
CONCLUSION: In the arterial phase, administration of a higher concentration of contrast material is effective for a significantly higher TLC.
© RSNA, 2002
Index terms: Computed tomography (CT), contrast enhancement • Computed tomography (CT), helical, 761.12115, 95.12915 • Hepatic arteries, CT, 95.12912, 95.12914, 95.12915 • Liver neoplasms, 761.323 • Liver neoplasms, CT, 761.12112, 761.12114, 761.12115
This article has been cited by other articles:
|
|
 |
|
  H. Kondo, M. Kanematsu, S. Goshima, Y. Tomita, T. Miyoshi, A. Hatcho, N. Moriyama, M. Onozuka, Y. Shiratori, and K. T. Bae Abdominal Multidetector CT in Patients with Varying Body Fat Percentages: Estimation of Optimal Contrast Material Dose Radiology, December 1, 2008; 249(3): 872 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Phillips, D. L. Stella, W. M. Rozen, M. Ashton, and G. I. Taylor Abdominal Wall CT Angiography: A Detailed Account of a Newly Established Preoperative Imaging Technique Radiology, October 1, 2008; 249(1): 32 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ma, A. E. Samir, N.-S. Holalkere, and D. V. Sahani Optimal Arterial Phase Imaging for Detection of Hypervascular Hepatocellular Carcinoma Determined by Continuous Image Capture on 16-MDCT Am. J. Roentgenol., September 1, 2008; 191(3): 772 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Fei, X. Du, Q. Yang, Y. Shen, P. Li, J. Liao, and K. Li 64-MDCT Coronary Angiography: Phantom Study of Effects of Vascular Attenuation on Detection of Coronary Stenosis Am. J. Roentgenol., July 1, 2008; 191(1): 43 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Behrendt, A. H. Mahnken, S. Stanzel, P. Seidensticker, E. Jost, R. W. Gunther, and G. Muhlenbruch Intraindividual Comparison of Contrast Media Concentrations for Combined Abdominal and Thoracic MDCT Am. J. Roentgenol., July 1, 2008; 191(1): 145 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yanaga, K. Awai, T. Nakaura, T. Namimoto, S. Oda, Y. Funama, and Y. Yamashita Optimal Contrast Dose for Depiction of Hypervascular Hepatocellular Carcinoma at Dynamic CT Using 64-MDCT Am. J. Roentgenol., April 1, 2008; 190(4): 1003 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Schindera, R. C. Nelson, S. Mukundan Jr, E. K. Paulson, T. A. Jaffe, C. M. Miller, D. M. DeLong, K. Kawaji, T. T. Yoshizumi, and E. Samei Hypervascular Liver Tumors: Low Tube Voltage, High Tube Current Multi Detector Row CT for Enhanced Detection Phantom Study Radiology, December 1, 2007; 246(1): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Chu, B. N. Joe, A. C. A. Westphalen, E. M. Webb, F. V. Coakley, and B. M. Yeh Patient-specific Time to Peak Abdominal Organ Enhancement Varies with Time to Peak Aortic Enhancement at MR Imaging Radiology, December 1, 2007; 245(3): 779 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ho, R. C. Nelson, and D. M. DeLong Determining Contrast Medium Dose and Rate on Basis of Lean Body Weight: Does This Strategy Improve Patient-to-Patient Uniformity of Hepatic Enhancement during Multi-Detector Row CT? Radiology, May 1, 2007; 243(2): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goshima, M. Kanematsu, H. Kondo, R. Yokoyama, T. Miyoshi, H. Nishibori, H. Kato, H. Hoshi, M. Onozuka, and N. Moriyama MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. Am. J. Roentgenol., July 1, 2006; 187(1): W25 - W32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Schima, R. Hammerstingl, C. Catalano, L. Marti-Bonmati, E. J. Rummeny, F. T. Montero, A. Dirisamer, B. Westermayer, M. Bellomi, D. Brisbois, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. Am. J. Roentgenol., June 1, 2006; 186(6): 1571 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Johnson and E. K. Fishman IV Contrast Selection for MDCT: Current Thoughts and Practice Am. J. Roentgenol., February 1, 2006; 186(2): 406 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Funama, K. Awai, Y. Nakayama, K. Kakei, N. Nagasue, M. Shimamura, N. Sato, S. Sultana, S. Morishita, and Y. Yamashita Radiation Dose Reduction without Degradation of Low-Contrast Detectability at Abdominal Multisection CT with a Low-Tube Voltage Technique: Phantom Study Radiology, December 1, 2005; 237(3): 905 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Bae, K. Awai, and Y. Yamashita Comparison of Moderate versus High Concentration of Contrast Media Injected at the Same Total Iodine Dose and Fixed Injection Duration * Drs Awai and Yamashita respond: Radiology, August 1, 2005; 236(2): 740 - 741. [Full Text] [PDF]
|
|
|
|
|
|
Y. Yagyu, K. Awai, M. Inoue, R. Watai, T. Sano, H. Hasegawa, and Y. Nishimura MDCT of Hypervascular Hepatocellular Carcinomas: A Prospective Study Using Contrast Materials with Different Iodine Concentrations Am. J. Roentgenol., May 1, 2005; 184(5): 1535 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Awai, M. Inoue, Y. Yagyu, M. Watanabe, T. Sano, S. Nin, R. Koike, Y. Nishimura, and Y. Yamashita Moderate versus High Concentration of Contrast Material for Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast at Multi-Detector Row CT Radiology, December 1, 2004; 233(3): 682 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saini Multi-Detector Row CT: Principles and Practice for Abdominal Applications Radiology, November 1, 2004; 233(2): 323 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Furuta, K. Ito, T. Fujita, S. Koike, A. Shimizu, and N. Matsunaga Hepatic Enhancement in Multiphasic Contrast-Enhanced MDCT: Comparison of High- and Low-Iodine-Concentration Contrast Medium in Same Patients with Chronic Liver Disease Am. J. Roentgenol., July 1, 2004; 183(1): 157 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murakami, T. Kim, M. Hori, and M. P. Federle Double Arterial Phase Multi-Detector Row Helical CT for Detection of Hypervascular Hepatocellular Carcinoma [letter] Radiology, December 1, 2003; 229(3): 931 - 932. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
